Fine‐needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions

Fine‐needle aspiration cytology (FNAC) is an established, highly accurate method for diagnosing breast lesions. However, in recent years there has been increased use of core biopsy (CB) in this setting. The aim of this study was to evaluate the accuracy of FNAC and compare the quality assessment parameters of FNAC and CB in palpable and nonpalpable breast lesions. Data regarding FNAC, CB, and excision biopsy (EB) diagnoses were retrieved from the archives of our department. A total of 4,367 FNAC samples from the years 1999–2001 was reviewed. Of these, corresponding histology results were available for 1,275 lesions, of which 1,248 were primary breast epithelial lesions (788 EB, 199 CB, 261 EB+CB). All cases were analyzed for sensitivity and specificity of FNAC. Cases with both FNAC and CB were compared and quality assessment parameters were calculated using the methodology detailed in the National Health Service Breast Screening Program guidelines. High specificity and sensitivity, as calculated for satisfactory specimens, were achieved with the use of both FNAC and CB. False‐positive and false‐negative diagnoses were seen in 7/404 (1.7%) and 45/635 (7.1%) of biopsy‐proven specimens sampled by FNAC. The corresponding values for CB were 0% and 5.7%, respectively. Inadequate sampling (15.1%) with use of FNAC was particularly seen in collagenous lesions and in submitted specimens sampled by physicians lacking experience with the FNAC procedure. FNAC is a valuable method, although moderately less sensitive than CB. CB is the preferred method for preoperative diagnosis when sampling FNAC provides scarce material and suspicion of a fibrotic and collagenous lesion such as lobular carcinoma and radial scar arises. FNAC is most accurate when experienced cytologists are available and when immediate assessment by professionals is performed for evaluation of material adequacy, so that additional aspirations can be done when needed. Diagn. Cytopathol. 2003;29:344–348. © 2003 Wiley‐Liss, Inc.

[1]  M Rubin,et al.  Use of fine needle aspiration for solid breast lesions is accurate and cost-effective. , 1997, American journal of surgery.

[2]  N. Sneige,et al.  Is a diagnosis of infiltrating versus in Situ ductal carcinoma of the breast possible in fine‐needle aspiration specimens? , 1998, Cancer.

[3]  K. Lindholm,et al.  Prediction of invasiveness by aspiration cytology applied to nonpalpable breast carcinoma and tested in 300 cases , 1997, Diagnostic cytopathology.

[4]  N. Sneige,et al.  Changing trends in breast fine‐needle aspiration: Results of the Papanicolaou society of cytopathology survey , 2000, Diagnostic cytopathology.

[5]  B. Fornage,et al.  Ultrasound‐guided fine‐needle aspiration (FNA) of nonpalpable breast lesions , 1999, Cancer.

[6]  K. Chew,et al.  Fine needle aspiration techniques for the characterization of breast cancers , 1994, Cancer.

[7]  S. Schnitt,et al.  Nonmalignant Lesions in Breast Core Needle Biopsies: To Excise or Not to Excise? , 2002, The American journal of surgical pathology.

[8]  J. Klijanienko,et al.  Ultrasound‐guided fine‐needle aspiration cytology of nonpalpable breast lesions , 1998, Cancer.

[9]  S. Martin,et al.  Core needle biopsy , 1997, Cancer.

[10]  M P Mano,et al.  Role of fine‐needle aspiration biopsy in breast lesions: Analysis of a series of 4,110 cases , 1998, Diagnostic cytopathology.

[11]  F. Abreo,et al.  Comparison of fine‐needle aspiration cytology and core biopsy for diagnosis of breast cancer , 2001, Diagnostic cytopathology.

[12]  M. Meunier,et al.  Fine needle aspiration cytology versus percutaneous biopsy of nonpalpable breast lesions. , 2002, European journal of radiology.

[13]  L. Layfield,et al.  Immediate on‐site interpretation of fine‐needle aspiration smears , 2001, Cancer.

[14]  T. Sauer,et al.  Fine needle aspiration cytology in the work‐up of mammographic and ultrasonographic findings in breast cancer screening: an attempt at differentiating in situ and invasive carcinoma , 2002, Cytopathology : official journal of the British Society for Clinical Cytology.

[15]  N. Dallimore,et al.  Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? , 2001, Journal of clinical pathology.

[16]  P. Gattuso,et al.  Unsatisfactory aspirates from fine‐needle aspiration biopsies: A review , 1995, Diagnostic cytopathology.

[17]  I. Ellis,et al.  Guidelines for cytology procedures and reporting on fine needle aspirates of the breast , 1994, Cytopathology : official journal of the British Society for Clinical Cytology.

[18]  K. Bloom,et al.  Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation. , 2002, American journal of surgery.

[19]  W. P. Evans,et al.  Rate of insufficient samples for fine‐needle aspiration for nonpalpable breast lesions in a multicenter clinical trial , 1998, Cancer.

[20]  N. Sneige,et al.  Can core needle biopsy replace fine‐needle aspiration cytology in the diagnosis of palpable breast carcinoma: A comparative study of 124 women , 1996, Cancer.